Pharmaceutical business Apontis Pharma, a portfolio company of Paragon Partners, has announced its intention to float on the Frankfurt Stock Exchange in Q2 2021.
Laboratory and imaging diagnostics service is valued at more than EUR 5bn
IK expanded its UK operations to include a local small-cap team headed by partner Tom Salmon in 2020
Asset manager nets a 10.7% IRR on the investment in its listed peer
Romanian cybersecurity company appoints JP Morgan and Morgan Stanley for a dual-track process